Abstract: The present invention describes an ophthalmic composition comprising diclofenac potassium, the use of said composition as a medicament for treating inflammatory conditions of the eye, for treating glaucoma or for treating ear inflammatory and/or painful conditions (otitis); as well as the use of diclofenac potassium in the preparation of a pharmaceutical composition for treating any inflammatory condition of the eye, for treating glaucoma or for treating ear inflammatory and/or painful conditions (otitis).

Abstract: The present invention describes an ophthalmic composition diclofenac potassium, the use of said composition as a medicament for treating inflammatory conditions of the eye, for treating glaucoma or for treating ear inflammatory conditions and/or painful conditions (otitis)-l as well as the use of diclofenac potassium in the preparation of a pharmaceutical composition for the treatment of any inflammatory condition of the eye, for treating glaucoma or for treating ear inflammatory and/or painful conditions (otitis).

Abstract: The present invention relates to the use of angiotensin antagonist or a pharmaceutically acceptable salt thereof for the treatment of normal tension glaucoma, wherein said angiotensin antagonist and salt thereof have pronunced selectivity for the AT1 receptor.

Abstract: Novel benzothiophene and benzofuran derivatives of the general formula I ##STR1## wherein X is oxygen or sulfur, R.sub.1 is hydrogen, halogen, C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 haloalkyl, R.sub.2 is hydrogen, halogen, C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 haloalkyl, R.sub.3 is hydrogen, C.sub.1 -C.sub.4 alkyl or halogen and R is a 4-cyano-3-pyrrole radical of which the N atom carries one of the following substituents:A: hydrogen or CO--R.sub.4 in which R.sub.4 is unsubstituted C.sub.1 C.sub.6 alkyl or C.sub.1 -C.sub.6 alkyl substituted by halogen or by C.sub.1 -C.sub.3 alkoxy; C.sub.3 -C.sub.6 alkenyl, C.sub.3 -C.sub.6 alkynyl, unsubstituted C.sub.1 -C.sub.6 alkoxy or C.sub.1 -C.sub.6 alkoxy substituted by halogen or by C.sub.1 -C.sub.3 alkoxy; C.sub.3 -C.sub.6 alkenyloxy, C.sub.3 -C.sub.6 cycloalkyl or tetrahydrofur2-yl;B: S-R.sub.5 in which R.sub.5 is C.sub.1 -C.sub.3 haloalkyl;C: CH(Y)R.sub.6 in which R.sub.6 is hydrogen or C.sub.1 -C.sub.8 haloalkyl and Y is hydroxy, halogen or OC(O)R.sub.